Piper Sandler Warns Strait of Hormuz Closure Could Push Oil to New Highs This Summer
Shah Metacorp Surges 6 on 498 Crore Rights Issue for Expansion and Renewable Energy Entry
T Rowe Prices Tony Wang Shifts AI Focus to Space and Bottlenecks After Nvidia Success
HarleyDavidson Analyst Report Highlights Market Position and Strategy
Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project
The Pothole Puzzle Britains 186bn Road Repair Backlog and Its Economic Impact
NWBI Q1 2026 Earnings Earnings Surpass Estimates as Stock Declines Amid Broader Market Pressure
Village Farms International VFF Q1 2026 Earnings EPS Misses Estimates Slightly Amid Undisclosed Revenue
INFU Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Slides Lower
CRGY Q1 2026 Earnings Earnings Surge Past Estimates as Operational Efficiency Drives Strong Results
Modiv Industrial Inc Class C MDV Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges
Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period
Ollies Bargain Outlet OLLI Gains 5 as Discount Retailer Shows Resilience
MVSTW Warrants Continue to Trade at Penny Levels Amid Minimal Price Action
Caledonia Mining CMCL Faces Selling Pressure Key Support Levels in Focus
Rezolve AI RZLV Dips 192 as Stock Approaches Support Zone
California Resources Corporation CRC Advances 131 Approaching Key Resistance Level
Hexcel Corporation Q1 2026 Earnings EPS Surges Past Estimates Signaling Robust Operational Efficiency
Navios Maritime Partners NMM Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds
EXFY Q1 2026 Earnings EPS Beats Estimates by 68 Stock Rises
Wintrust Financial WTFCN Q1 2026 Earnings Solid EPS Beat Driven by Strong Net Interest Income
AVX Q1 2026 Earnings Narrow Loss Reported Amidst Limited Disclosure
CZNC Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher
UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit
LSBK Q3 2025 Earnings EPS of 032 Stands Alone Amid Sparse Disclosure
Foghorn Therapeutics FHTX Rises 144 as Biotech Stock Tests Key Resistance at 443